Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules

NCT00652743 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00652743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00652743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
March 23, 2008
Completion date
June 8, 2011
Enrollment
845 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

influenza